These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9179754)
41. Fine needle aspiration diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma. A case report. Gibbons D; de las Morenas A Acta Cytol; 1997; 41(4 Suppl):1269-72. PubMed ID: 9990256 [TBL] [Abstract][Full Text] [Related]
42. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683 [TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Maeda T; Tsuneyoshi M; Takenaka K; Sugimachi K Cancer; 1997 Aug; 80(3):514-6. PubMed ID: 9241086 [No Abstract] [Full Text] [Related]
45. [Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules]. Kwon YM; Lee SK; Kim JS; Ro JY; Yu ES Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):223-7. PubMed ID: 12499809 [No Abstract] [Full Text] [Related]
46. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Ramos-Vara JA; Miller MA; Johnson GC Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796 [TBL] [Abstract][Full Text] [Related]
47. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Fisher HP; Doppl W; Osborn M; Altmannsberger M Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(2):71-6. PubMed ID: 2467436 [TBL] [Abstract][Full Text] [Related]
48. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma. Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771 [TBL] [Abstract][Full Text] [Related]
49. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature. Chin S; Kim Z Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887 [TBL] [Abstract][Full Text] [Related]
51. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727 [TBL] [Abstract][Full Text] [Related]
52. [An autopsy case with a combination of hepatocellular carcinoma and cholangiocellular carcinoma]. Sugihara S; Nakahara T; Maruiwa M; Kojiro M; Iwai I; Tanaka M; Hirai K; Majima Y; Tanikawa K Gan No Rinsho; 1987 Feb; 33(2):205-10. PubMed ID: 3031334 [TBL] [Abstract][Full Text] [Related]
53. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. Sasaki M; Sato Y; Nakanuma Y Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656 [TBL] [Abstract][Full Text] [Related]
54. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma. Fujii T; Zen Y; Nakanuma Y J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135 [TBL] [Abstract][Full Text] [Related]
55. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma. Watanabe M; Akagi S; Hamamoto S Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582 [No Abstract] [Full Text] [Related]
56. Clinical findings and diagnosis in a case of cholangiocellular carcinoma in a horse. Conti MB; Marchesi MC; Zappulla F; Buttarelli D; Lepri E; Passamonti F; Galletti S; Rucco G; Rueca F Vet Res Commun; 2008 Sep; 32 Suppl 1():S271-3. PubMed ID: 18685982 [No Abstract] [Full Text] [Related]
57. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma. Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746 [TBL] [Abstract][Full Text] [Related]
58. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature. Wu C; Bai DS; Jiang GQ; Jin SJ World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169 [TBL] [Abstract][Full Text] [Related]
59. [A case of combined or mixed hepatocellular and cholangiocarcinoma with sarcomatous components--immunohistochemical characteristics and histogenesis]. Nakasho K; Yamanaka N; Okamoto E Nihon Shokakibyo Gakkai Zasshi; 1996 Mar; 93(3):206-11. PubMed ID: 8721118 [No Abstract] [Full Text] [Related]
60. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan. Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]